Quanta Pharma GHK-Cu 50mg is a pharmaceutical-grade copper-binding tripeptide naturally found in human plasma, saliva, and urine. This lyophilised vial from Quanta Pharma offers researchers a high-purity compound for advanced studies in skin regeneration, wound healing, collagen synthesis, and anti-ageing research. The 50mg vial provides excellent value for extended research protocols. Available for UK delivery with fast dispatch.
Analiza Białek Finished Product Verified
Independent testing of the sealed vial by a leading EU laboratory
53.41mg Actual Content 50mg Label Claim 107% Accuracy 99% Purity W8Z13CJ4
Quanta Pharma GHK-Cu Specifications
Peptide GHK-Cu Also Known As Copper Peptide Dosage 50mg/vial Sequence Tripeptide + Cu²⁺ Form Lyophilised Storage 2-8°C GHK-Cu 50mg by Quanta Pharma
Quanta Pharma GHK-Cu Research Benefits
- Collagen synthesis: Researched extensively for stimulating collagen I, III, and elastin production in skin tissue
- Wound healing: Demonstrates accelerated tissue repair and reduced scarring in research models
- Anti-ageing properties: Investigated for reversing signs of skin ageing and improving skin elasticity
- Hair follicle support: Shows potential in studies examining hair growth stimulation and follicle health
- Anti-inflammatory action: Modulates inflammatory responses and supports tissue remodelling processes
How Quanta Pharma GHK-Cu Works
GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper) is a naturally occurring tripeptide with a strong affinity for copper ions. It was first isolated from human plasma and is found throughout the body, with levels declining significantly with age. Quanta Pharma produces this peptide to exacting pharmaceutical standards, independently verified by Analiza Białek at 99% purity with content confirmed at 53.41mg against a 50mg label claim.
Research indicates Quanta Pharma GHK-Cu works through multiple mechanisms including activation of wound healing genes, attraction of immune cells and fibroblasts to injury sites, stimulation of collagen and glycosaminoglycan synthesis, and regulation of metalloproteinase activity. These combined actions make it a powerful compound for tissue regeneration research.
Quanta Pharma GHK-Cu vs Other Copper Peptides
While several copper peptides exist, GHK-Cu from Quanta Pharma is the most extensively researched variant. Unlike synthetic alternatives, GHK-Cu is bioidentical to the naturally occurring compound in human plasma. This makes Quanta Pharma GHK-Cu the preferred choice for researchers studying physiological wound healing and skin regeneration pathways.
Why Choose Quanta Pharma GHK-Cu?
Quanta Pharma is renowned for producing pharmaceutical-grade peptides with exceptional purity and accurate dosing. The 50mg vial of Quanta Pharma GHK-Cu offers excellent value for extended research protocols requiring consistent, high-quality compound. Every Quanta Pharma product undergoes rigorous quality control, and this finished-product vial has been independently assayed at 99% purity with verified content of 53.41mg, giving researchers genuine confidence in every batch.
⚠️ FOR LABORATORY RESEARCH USE ONLY
NOT FOR HUMAN OR VETERINARY DIAGNOSTIC OR THERAPEUTIC USE
Safety Classification:
For use by qualified research personnel only. Keep detailed records of usage and storage as per UK research regulations.
Legal Notice: This product is exclusively intended for in vitro laboratory research conducted in controlled environments by qualified research staff. It is not for pharmaceutical, domestic, or any other applications. The purchaser accepts that acquiring and using this material is governed by all relevant UK regulations concerning research chemicals.
Related products
